Back to Search
ANDREI IAGARU, MD
MD
Nuclear Radiology Physician
NPI: 1750404752IndividualAccepts Medicare
Education
OTHER
Class of 2000
Research & Publications (20)
131I-Tositumomab (Bexxar) vs. 90Y-Ibritumomab (Zevalin) therapy of low-grade refractory/relapsed non-Hodgkin lymphoma.
PMID 19543946·Mol Imaging Biol·2010
8-other
Novel strategy for a cocktail 18F-fluoride and 18F-FDG PET/CT scan for evaluation of malignancy: results of the pilot-phase study.
PMID 19289439·J Nucl Med·2009
7-preclinical
18F-FDG PET/CT evaluation of patients with ovarian carcinoma.
PMID 18987524·Nucl Med Commun·2008
8-other
90Y-ibritumomab therapy in refractory non-Hodgkin's lymphoma: observations from 111In-ibritumomab pretreatment imaging.
PMID 18927323·J Nucl Med·2008
8-other
Rhabdomyosarcoma diffusely metastatic to the bone marrow: suspicious findings on 99mTc-MDP bone scintigraphy confirmed by (18)F-18 FDG PET/CT and bone marrow biopsy.
PMID 18648808·Eur J Nucl Med Mol Imaging·2008
5-case
Perspectives of molecular imaging and radioimmunotherapy in lymphoma.
PMID 18619379·Radiol Clin North Am·2008
6-review
Molecular imaging can accelerate anti-angiogenic drug development and testing.
PMID 17726490·Nat Clin Pract Oncol·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 3023 Summit St Fl 3
Oakland, CA 94609 - Phone
- (925) 621-7700
Quick Facts
- NPI
- 1750404752
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 2
- Years in Practice
- 26
- Publications
- 20
Are you this provider?
Claim Your Profile